BDTX Earnings Date: Nov 5, 2026 (Estimated) — Black Diamond Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is BDTX's next earnings date?
Black Diamond Therapeutics, Inc. (BDTX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.06 on revenue of $8.3M.
How did BDTX do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Black Diamond Therapeutics, Inc. posted EPS of -$0.17 versus the -$0.20 estimate, a beat of 15.0%. Revenue was $0 against a $5.6M estimate. The stock's 1-day post-earnings move was +7.3%.
How much does BDTX stock move after earnings?
BDTX beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 5.8% (up or down) in the day after earnings.
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The firm is also progressing BDTX-1535, a brain-penetrant inhibitor addressing a range of EGFR mutations, including conventional, inherent resistance, and acquired resistance forms. Concurrently, it is advancing BDTX-4933, another brain-penetrant inhibitor targeting oncogenic BRAF alterations across Class I, II, and III categories. Black Diamond maintains a strategic alliance with OpenEye Scientific Software, Inc. Established in 2014, the company was initially known as ASET Therapeutics, Inc. before adopting its current name, Black Diamond Therapeutics, Inc., in January 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.20 | -0.17 | +15.00% | $0 | ✅ Beat | +7.26% | +17.32% | +17.32% |
| 2026-05-07 | Q1 2026 | -0.21 | -0.16 | +23.81% | $0 | ✅ Beat | -3.55% | +1.42% | -30.14% |
| 2026-03-16 | Q4 2025 | -0.17 | -0.27 | -58.82% | $0 | ❌ Miss | +1.83% | -1.83% | +31.05% |
| 2025-11-06 | Q3 2025 | -0.22 | -0.15 | +31.82% | $0 | ✅ Beat | +2.84% | +25.84% | -31.01% |
| 2025-08-07 | Q2 2025 | -0.24 | -0.19 | +20.83% | $0 | ✅ Beat | -15.24% | +2.97% | +9.29% |
| 2025-03-06 | Q4 2024 | -0.31 | -0.28 | +9.68% | $0 | ✅ Beat | -1.05% | -13.16% | -26.32% |
| 2024-11-05 | Q3 2024 | -0.35 | -0.28 | +20.00% | $0 | ✅ Beat | +8.70% | +13.04% | -17.73% |
| 2024-08-06 | Q2 2024 | -0.39 | -0.36 | +7.69% | $0 | ✅ Beat | -5.57% | -11.70% | +6.04% |
Showing last 8 quarters.